Publication:

The current benefit of genome sequencing compared to exome sequencing in patients with developmental or epileptic encephalopathies

Date

Date

Date
2023
Journal Article
Published version

Citations

Citation copied

Grether, A., Ivanovski, I., Russo, M., Begemann, A., Steindl, K., Abela, L., Papik, M., Zweier, M., Oneda, B., Joset, P., & Rauch, A. (2023). The current benefit of genome sequencing compared to exome sequencing in patients with developmental or epileptic encephalopathies. Molecular Genetics & Genomic Medicine, 11, e2148. https://doi.org/10.1002/mgg3.2148

Abstract

Abstract

Abstract

Background: As the technology of next generation sequencing rapidly develops and costs are constantly reduced, the clinical availability of whole genome sequencing (WGS) increases. Thereby, it remains unclear what exact advantage WGS offers in comparison to whole exome sequencing (WES) for the diagnosis of genetic diseases using current technologies.

Methods: Trio-WGS was conducted for 20 patients with developmental or epileptic encephalopathies who remained undiagnosed after WES and chromosomal microarray analysis.

Results: A diagn

Metrics

Downloads

76 since deposited on 2023-02-15
Acq. date: 2025-11-12

Views

76 since deposited on 2023-02-15
Acq. date: 2025-11-12

Additional indexing

Creators (Authors)

Journal/Series Title

Journal/Series Title

Journal/Series Title

Volume

Volume

Volume
11

Number

Number

Number
5

Page range/Item number

Page range/Item number

Page range/Item number
e2148

Item Type

Item Type

Item Type
Journal Article

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Keywords

Genetics (clinical), Genetics, Molecular Biology, diagnostic yield, epileptic encephalopathy, whole exome sequencing, whole genome sequencing

Language

Language

Language
English

Publication date

Publication date

Publication date
2023-05-01

Date available

Date available

Date available
2023-02-15

Publisher

Publisher

Publisher

ISSN or e-ISSN

ISSN or e-ISSN

ISSN or e-ISSN
2324-9269

Additional Information

Additional Information

Additional Information
ETHICAL COMPLIANCE The study was approved by the ethical committee of the Kanton of Zurich (StV 11/09 and PB_2016-02520) and informed consent of the participating individuals or their legal guardians was obtained. DATA AVAILABILITY STATEMENT Raw data or samples are not publically available due to consent restrictions.

OA Status

OA Status

OA Status
Gold

Free Access at

Free Access at

Free Access at
Pubmed ID

PubMed ID

PubMed ID

PubMed ID

Related URLs

Related URLs

Related URLs

Metrics

Downloads

76 since deposited on 2023-02-15
Acq. date: 2025-11-12

Views

76 since deposited on 2023-02-15
Acq. date: 2025-11-12

Citations

Citation copied

Grether, A., Ivanovski, I., Russo, M., Begemann, A., Steindl, K., Abela, L., Papik, M., Zweier, M., Oneda, B., Joset, P., & Rauch, A. (2023). The current benefit of genome sequencing compared to exome sequencing in patients with developmental or epileptic encephalopathies. Molecular Genetics & Genomic Medicine, 11, e2148. https://doi.org/10.1002/mgg3.2148

Gold Open Access
Loading...
Thumbnail Image

Files

Files

Files
Files available to download:1

Files

Files

Files
Files available to download:1
Loading...
Thumbnail Image